Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,289,902 papers from all fields of science
Search
Sign In
Create Free Account
FN18-CRM9
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (3)
Diphtheria Toxin
Monoclonal Antibodies
Recombinant Fusion Proteins
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Effect of pre-existing anti-diphtheria toxin antibodies on T cell depletion levels following diphtheria toxin-based recombinant anti-monkey CD3 immunotoxin treatment.
A. Matar
,
V. Pathiraja
,
+6 authors
Christene A. Huang
Transplant Immunology
2012
Corpus ID: 6895211
2008
2008
Retraction: Peritransplant tolerance induction with anti-CD3-immunotoxin: a matter of proinflammatory cytokine control.
Judith M. Thomas
,
J. Contreras
,
+11 authors
J. Shiloach
Transplantation
2008
Corpus ID: 29920009
BACKGROUND Tolerance is gaining momentum as an approach to reduce lifelong immunosuppressive therapy while improving transplant…
Expand
2001
2001
IMMUNOTOXIN FN18-CRM9 INDUCES STRONGER T CELL SIGNALING THAN UNCONJUGATED MONOCLONAL ANTIBODY FN1812
M. Hamawy
,
M. Tsuchida
,
C. Cho
,
E. Manthei
,
J. Fechner
,
S. Knechtle
Transplantation
2001
Corpus ID: 2449512
Background. The T-cell receptor (TCR)/CD3 complex is the target of therapeutic strategies aimed at prolonging allograft survival…
Expand
2000
2000
Increased glomerular deposits of von Willebrand factor in chronic, but not acute, rejection of primate renal allografts.
A. Lagoo
,
P. Buckley
,
+9 authors
S. Knechtle
Transplantation
2000
Corpus ID: 31807946
BACKGROUND In our previously described primate renal allograft model, T cell ablation leads to long-term graft survival. The role…
Expand
2000
2000
SKIN ALLOGRAFT ACCEPTANCE IN LONG‐SURVIVING NONHUMAN PRIMATE RENAL ALLOGRAFT RECIPIENTS TREATED WITH FN18‐CRM9.: Abstract# 501 Poster Board #‐Session: P141‐II
S. Knechtle
,
J. Fechner
,
Yinchen Dong
,
K. Brunner
,
C. Cho
,
M. Hamawy
2000
Corpus ID: 74772119
1999
1999
Activation of T lymphocytes for adhesion and cytokine expression by toxin-conjugated anti-CD3 monoclonal antibodies.
M. Hamawy
,
M. Tsuchida
,
E. Manthei
,
Y. Dong
,
J. Fechner
,
J. S. Knechtle
Transplantation
1999
Corpus ID: 25388226
BACKGROUND Immunosuppressive drugs that target T cells are useful for prolonging allograft survival. The anti-CD3 immunotoxin…
Expand
Highly Cited
1998
Highly Cited
1998
Analysis of primate renal allografts after T-cell depletion with anti-CD3-CRM9.
N. Armstrong
,
P. Buckley
,
+6 authors
S. Knechtle
Transplantation
1998
Corpus ID: 23143714
BACKGROUND FN18-CRM9 is a CD3-specific immunotoxin that is capable of depleting CD3+ T cells. Pretreatment of rhesus monkeys with…
Expand
Highly Cited
1997
Highly Cited
1997
Split tolerance induced by immunotoxin in a rhesus kidney allograft model.
J. Fechner
,
D. Vargo
,
+7 authors
S. Knechtle
Transplantation
1997
Corpus ID: 30916279
BACKGROUND Renal allografts were performed in rhesus monkeys using FN18-CRM9, a potent immunotoxin capable of depleting T cells…
Expand
1997
1997
Genetic construction and characterization of an anti-monkey CD3 single-chain immunotoxin with a truncated diphtheria toxin.
S. Ma
,
H. Hu
,
J. Thompson
,
S. Stavrou
,
J. Scharff
,
D. Neville
Bioconjugate chemistry
1997
Corpus ID: 38311128
We have previously developed a chemically conjugated anti-rhesus monkey CD3 immunotoxin FN18-CRM9 that can deplete in vivo T…
Expand
1997
1997
Depletion of T lymphocytes with immunotoxin retards the progress of experimental allergic encephalomyelitis in rhesus monkeys.
Huaizhong Hu
,
S. Stavrou
,
+4 authors
David M. Neville
Cellular Immunology
1997
Corpus ID: 46514672
FN18-CRM9 is an anti-rhesus anti-CD3 immunotoxin that can transiently deplete T cells to 1% of initial values in both the blood…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required